Ingevity : CJS Securities New Ideas Conference Presentation

CJS New Ideas Conference

John Fortson, CEO Mary Hall, CFO

January 12, 2022

PURIFY I PROTECT I ENHANCE

Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," "believes," "anticipates," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, results of operations and cash flows; financing plans; business strategies and expectations; operating plans; impact of COVID-19; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost-reduction initiatives, plans and objectives; litigation related strategies and outcomes; markets for securities and expected future repurchases of shares, including statements about the manner, amount and timing of repurchases. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, adverse effects from the COVID-19 pandemic; adverse effects of general economic and financial conditions; risks related to international sales and operations; impacts of currency exchange rates and currency devaluation; compliance with U.S. and foreign regulations concerning our

operations; changes in trade policy, including the imposition of tariffs; adverse conditions in the global automotive market or adoption of alternative and new technologies; competition from producers of alternative products and new technologies, and new or emerging competitors; competition from infringing intellectual property activity; worldwide air quality standards; a decrease in government infrastructure spending; the impact of adverse conditions in cyclical end markets on demand for engineered polymers products; declining volumes and downward pricing in the printing inks market; the limited supply of or lack of access to sufficient crude tall oil; a prolonged period of low energy prices; the impact of the United Kingdom's withdrawal from the European Union; exposure to unknown or understated liabilities from the acquisition of the Perstorp Holding

AB's Capa® caprolactone business; the provision of services by third parties at several facilities; supply chain disruptions; natural disasters, such as hurricanes, winter or tropical storms, earthquakes, tornados, floods, fires; other unanticipated problems such as labor difficulties, equipment failure or unscheduled maintenance and repair; attracting and retaining key

personnel; protection of intellectual property and proprietary information; information technology security breaches and other disruptions; complications with designing and implementing our new enterprise resource planning system; adverse litigation judgments and related costs; government policies and regulations, including, but not limited to, those affecting the environment, climate change, tax policies, tariffs and the chemicals industry; and lawsuits arising out of environmental damage or personal injuries associated with chemical or other manufacturing processes and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K, our Form 10-Q for the quarter ended September 30, 2021, and other periodic filings. These forward-looking statements speak only as of the date of this presentation. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this presentation.

Non-GAAPFinancial Measures: This presentation includes certain non‐GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. Reconciliations of non‐GAAP financial measures to GAAP financial measures are provided within the Appendix to this presentation. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided.

2

Contents

1 Corporate Overview

2 Financial Review

3 Strategic Growth and Innovation

3

1| Corporate Overview

4

We Create High Value-Added Products Largely

From Renewable Raw Materials

A leading global provider of specialty chemical products and technologies that purify, protect and enhance

• Reporting segments are:
• • Performance Chemicals, comprised of specialty chemicals and engineered polymers
  • Performance Materials, which includes high-performanceactivated carbon
• High value-added products created from renewable raw materials

2020 revenues by segment		2020 revenues by geography
			S. America 1%
Performance		APAC
Materials		29%
42%	Performance		N. America
	55%

Chemicals	EMEA
58%
15%

2020 Revenues	$1.216B		Over 75% of 2020 revenue came from renewable raw materials
2020 Adj. EBITDA (1)	$397.9M
	Renewable raw
Total Employment	~1,850
	materials
Manufacturing Sites	9	77%	Performance
Technical Centers	6
	Trad'l	Materials
				Hardwood sawdust
Principal Offices	10		feedstocks
		23%
Countries	75			Performance
				Chemicals

5	Source: company information	Crudetall oil
(1) See Appendix for slide 11